key: cord-0259518-tubveppd
authors: Pellegrina, D.; Bahcheli, A. T.; Krassowski, M.; Reimand, J.
title: Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants
date: 2021-11-24
journal: nan
DOI: 10.1101/2021.11.22.21266712
sha: a4e5e02a66d634081d9614ca3cc90069015474fd
doc_id: 259518
cord_uid: tubveppd

SARS-CoV-2 infection hijacks signaling pathways and induces protein-protein interactions between human and viral proteins. Human genetic variation may impact SARS-CoV-2 infection and COVID-19 pathology; however, the role of genetic variation in these signaling networks remains uncharacterized. We studied human single nucleotide variants (SNVs) affecting phosphorylation sites modulated by SARS-CoV-2 infection, using machine learning to identify amino acid changes altering kinase-bound sequence motifs. We found 2033 infrequent phosphorylation-associated SNVs (pSNVs) that are enriched in sequence motif alterations, potentially reflecting the evolution of signaling networks regulating host defenses. Proteins with pSNVs are involved in viral life cycle processes and host responses, including regulators of RNA splicing and interferon response, as well as glucose homeostasis pathways with potential associations with COVID-19 co-morbidities. Certain pSNVs disrupt CDK and MAPK substrate motifs and replace these with motifs recognized by Tank Binding Kinase 1 (TBK1) involved in innate immune responses, indicating consistent rewiring of infection signaling networks. Our analysis highlights potential genetic factors contributing to the variation of SARS-CoV-2 infection and COVID-19 and suggests leads for mechanistic and translational studies.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the coronavirus disease 31 2019 (COVID-19) pandemic has caused millions of deaths worldwide and continues to evolve as 32 more pathogenic and infectious variants of the virus emerge. The clinical manifestations and 33 outcomes of COVID-19 are complex, ranging from asymptomatic infection to fatal respiratory 34 and multi-organ failure, as well as long-term symptoms after recovery. Risk factors of severe 35 disease include advanced age, a weakened immune system, and pre-existing health conditions 36 such as hypertension, diabetes, and obesity 1 . Ethnic and demographic patient characteristics that 37 are at least partially explained by socio-economic factors also affect disease risk 2-4 . Recent 38 genome-wide association studies (GWAS) of COVID-19 have shed light on human genetic 39 variation contributing to SARS-CoV-2 disease burden and mortality rates, highlighting genes 40 associated with ABO blood groups, antiviral pathways and tyrosine kinase signaling 5-7 . 41

However, GWAS findings often occur in intergenic regions where molecular mechanisms 42 remain elusive, and rare variants potentially contributing to disease are challenging to detect. 43

Thus, additional work is needed to find and interpret genetic variants contributing to SARS- CoV-2 infection 9 . Sequence motif analysis was used to evaluate pSNV impact to predict gains and losses of kinase binding sites. Genes, pathways, and molecular interaction networks with frequent pSNVs were analyzed.

B. pSNVs of four functional classes were studied: (1) motif-rewiring pSNVs altering sequence motifs in kinase binding sites (MIMP posterior prob > 0.5), (2) direct pSNVs altering phosphorylated residues, and (3-4) pSNVs with no motif-rewiring predictions proximal and distal to phosphosites (±1-2 and ±3-7 residues, respectively).

Expected numbers of pSNVs (grey) represent control phosphosites sampled randomly from the proteome.

Empirical P-values and pSNV counts are shown. pSNVs predicted to cause rewiring of sequence motifs are enriched compared to controls (shown in red). C. Impact of motif-rewiring pSNVs on protein phosphorylation.

Pie chart shows pSNVs predicted to cause loss of phosphosites (i.e., pSNVs substituting phospho-residues and/or disrupting sequence motifs; blue), gain of phosphosites (i.e., pSNVs inducing new sequence motifs; orange), and motif switches (pSNVs erasing one motif and inducing another motif). D. A subset of pSNVs occur at highconfidence binding sites of kinases. Bar plot shows the top 15 kinases whose binding sites have the largest numbers of pSNVs.

RESULTS 83 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint SARS-CoV-2 associated phosphosites are enriched in pSNVs rewiring kinase binding 84 motifs 85

To examine the human genetic variation in signaling networks responding to SARS-CoV-2 86 infection, we studied exome sequencing data of 124,748 individuals from 16 populations in the 87 gnomAD dataset 23 , focusing on 1,111,194 amino acid substitutions that were observed at least 88 once per 10,000 individuals in at least one of the populations (AFpopmax > 10 -4 ). We defined 89 phosphorylation-associated SNVs (pSNVs) as missense SNVs (i.e., amino acid substitutions) 90 that affected 1530 host phosphosites differentially phosphorylated in SARS-CoV-2 infection 91 based on an earlier phosphoproteomics study (FDR < 0.05; 24h timepoint) 9 . We mapped pSNVs 92 in flanking windows of ±7 amino acid residues around phosphorylated residues to study 93 sequence motifs bound by kinases ( Figure 1A) . To predict the functional impact of pSNVs on 94 protein phosphorylation, we evaluated the effects of pSNVs on 125 types of sequence motifs 95 bound by kinases of 77 families. We used MIMP 24 , a machine learning method trained on 96 kinase binding sequences, that evaluates whether a pSNV disrupts an existing motif or creates a 97 new motif relative to the reference protein sequence. Higher Bayesian posterior probabilities 98 computed by MIMP reflect an increased likelihood of pSNVs causing rewiring of sequence 99 motifs. 100

We found 2,033 pSNVs in 987 SARS-CoV-2 -associated phosphosites and 693 genes and 101 assigned these to four classes based on their predicted functional impact ( Figure 1B , 102 Supplementary Table 1) . First, direct pSNVs (99 or 5%) replaced central phospho-residues and 103 caused loss of phosphosites, likely representing the pSNV class of highest impact. Second, motif-104 rewiring pSNVs (410 or 20%) created or disrupted sequence motifs, potentially causing gains or 105 losses kinase binding at the phosphosites (MIMP posterior prob > 0.5). The two remaining 106 classes of pSNVs lacked functional predictions based on sequence analysis and included 1527 107 (75%) pSNVs annotated as proximal or distal to the closest phosphosite. When combining direct 108 and motif-rewiring pSNVs, loss of phosphorylation through motif disruption or phospho-residue 109 replacement was predicted for 354 pSNVs. 87 pSNVs induced new sequence motifs at SARS-110

CoV-2-associated phosphosites and were predicted to cause gain of phosphorylation ( Figure 1C , 111

Overall, hundreds of pSNVs in the human population are predicted to alter SARS-CoV-2 driven 114 signaling in host cells through the range of kinase sequence motifs we studied. 115

We evaluated the statistical significance of these potentially functional pSNVs by randomly 116 sampling human phosphosites as controls. Compared to experimentally determined phosphosites 117 in the human proteome, SARS-CoV-2 associated phosphosites were enriched in motif-rewiring 118 pSNVs (410 pSNVs observed vs. 321 ± 21 pSNVs expected; P < 10 -4 ) ( Figure 1B) . In contrast, 119 direct pSNVs replacing central phospho-residues, as well as proximal and distal pSNVs lacking 120 motif-based predictions were found less frequently in SARS-CoV-2 associated phosphosites. 121 Some pSNVs (213 or 10%) occurred at well-defined phosphosites where the phosphorylating 122 kinases have been identified previously, such as cyclin dependent kinases, casein 2 kinases, 123 checkpoint kinases, and MAP kinases ( Figure 1D ), in agreement with studies of the human 124 signaling network modulated upon SARS-CoV-2 infection 9 and adding confidence to our 125 sequence-based predictions of pSNV impact. Enrichment of motif-rewiring pSNVs suggests that 126 the signaling network responding to SARS-CoV-2 infection in humans may vary structurally 127 such that certain kinase-substrate interactions are gained or lost some individuals. This may 128 reflect positive evolutionary selection in adaptation to viral infection and potentially cause 129 variation in SARS-CoV-2 infection and COVID-19 disease course. 130 131 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint Genes are scored by the probability of at least one pSNV altering SARS-CoV-2-associated phosphosites. B.

Example of a top gene with pSNVs: TRIM28, a transcriptional and epigenetic regulator involved in innate immune response, includes five pSNVs in two phosphosites: S473 phosphorylated by CHEK and MAPKAP2 kinases, and the phosphosite S50 with no known kinase. C. The pSNV S473L in TRIM28 substitutes the phospho-residue and disrupts a CHEK1 sequence motif with a high-confidence prediction of motif alteration (MIMP posterior prob > 0.99). the pSNV potentially alters the regulation of interferons by TRIM28. D. pSNVs . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint are enriched in biological processes and molecular pathways (ActivePathways, FDR < 0.1). The enrichment map is a network of pathways and processes as nodes that are connected by edges if the pathways share many genes.

Each subnetwork represents a distinct functional theme. Top genes with pSNVs are listed for each theme and include additional genes found in the pathway analysis (gene FDR < 0.25). E. Tissue-specific expression of genes with frequent pSNVs, as detected by enrichment analysis of Human Protein Atlas gene sets (ActivePathways, To interpret the human genetic variation of signaling networks responding to SARS-CoV-2 183 infection, we asked if the genes with frequent pSNVs converged to biological processes, 184 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The genes were also often expressed in lymph nodes and spleen, which are damaged by SARS-208

CoV-2 infection 40 . Brain and nervous system tissues, including cerebral cortex, hippocampus, 209 and peripheral nerves were also identified among enriched gene expression signatures, in line 210 with evidence of broad cellular perturbations of brain tissues in severe COVID-19 41 . Gene 211 expression signatures of skin, kidney, pancreas, colon, liver, and female reproductive tissues 212 were also identified. Tissue-specific enrichments were partially driven by genes with high 213 expression in most tissues, such as those involved in RNA splicing (SRRM2, BCLAF1), 214 interferon regulation (TRIM28), cell cycle (NUMA1, SUN2) and DNA damage response (MSH6). 215 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint SARS-CoV-2 affects diverse human tissues directly through the ACE2 receptor and indirectly 216 through inflammation and immune response dysregulation, causing broad organ damage in 217 severe disease 42 . Pathway annotations and expression patterns of genes with pSNVs suggest 218 these multifunctional genes and their genetic variants may contribute to SARS-CoV-2 infection 219 and COVID-19 through various pathways and mechanisms. 220 We asked if the pSNVs could be associated directly with risk of COVID-19, by analyzing the 352 genome-wide association study (GWAS) of the COVID-19 Host Genetics Initiative that explored 353 the genetic variation of nearly 50,000 COVID-19 patients using genotyping and imputation 6 . 354

Only a minority of pSNVs we identified were reported in the GWAS (66 or 4%). This low 355 coverage is likely explained by the overall low allele frequency of most pSNVs that restricts 356 their imputation and risk assessment in patient cohorts. We found a few pSNVs with nominal 357 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint statistical associations with COVID-19 risk, however, the associations were not significant after 358 multiple testing correction (all FDR > 0.15). 359

Collectively, these data suggest that pSNVs may mediate topological variation in signaling 360 networks that respond to SARS-CoV-2 infection. Since most pSNVs occur infrequently in the 361 human population, associating these with clinical risk using current datasets is challenging. 362

Focused genetic association studies and mechanistic experiments are needed to confirm and 363 characterize these predictions, and further evaluate their clinical potential. 364 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint is needed to associate our functional predictions of infrequent pSNVs with patient risk and co-395 morbidities, and to enable the development of prognostic and predictive biomarkers. The 396 candidate genes, pathways, and kinases identified in this study enable functional genomics 397 screens and phenotypic experiments that may lead to further mechanistic understanding of 398 SARS-CoV-2 infection and COVID-19. The biological processes and kinase signaling networks 399 we identified involve known drug targets, some of which have already been proposed in recent 400 studies. Thus, our findings have the potential to contribute to genome-guided risk predictions and 401 development of therapies for the current and future pandemics. 402 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ;

Host phosphorylation sites. Protein phosphosites significantly differentially phosphorylated in 404 SARS-CoV-2 infection were retrieved from the phospho-proteomics study by Bouhaddou et al 9 . 405

We mapped the phosphosites to canonical protein isoforms (hg19) using the ActiveDriverDB 44 406 database. SARS-CoV-2 associated phosphosites detected at the 24h timepoint were filtered for 407 significance (FDR < 0.05 in infected cells; FDR > 0.05 in controls). Sites corresponding to non-408 phosphorylated residues in human proteins were removed (i.e., residues other than S, T, or Y). proximal and distal (within 1-2 and 3-7 residues from phosphosite, respectively, with no motif-427 rewiring prediction). In the cases where multiple adjacent phosphosites were found to match a 428 pSNV, the highest-impact phosphosite was used. Motif-rewiring predictions were derived using 429 the MIMP method 24 , with the database of high-confidence kinase position weight matrices 430 (PWMs) (by setting the parameter model.data = hconf), a posterior probability cutoff (prob > 431 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint 0.5), and inclusion of central residues for rewiring predictions (include.cent = TRUE). To score 432 each pSNV, the kinase motif (i.e., the PWM) with the largest posterior probability was selected. 433

To prioritize pSNVs causing motif switches, both posterior probabilities (i.e., the top motif gain 434 and loss) were selected and aggregated as probswitch = 1 - (1 -probgain)(1 -probloss) , 435 corresponding to the combined probability of the pSNV causing either a gain or a loss of a motif. 436

Evaluating the enrichment of motif-rewiring pSNVs. Randomly sampled phosphosites were used 437 to evaluate the expected numbers of pSNVs with functional impact predictions (i.e., direct, 438 motif-rewiring, proximal, and distal pSNVs). We randomly sampled 10,000 sets of phosphosites 439 from the human phospho-proteome using datasets from ActiveDriverDB as controls, in equal 440 numbers to SARS-CoV-2 associated phosphosites. Control sites were annotated using gnomAD 441 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Analysis of population frequency and disease annotations of pSNVs. Allele frequencies of 486 pSNVs in human populations were reported as shown in the gnomAD dataset. We also studied 487 disease associations of pSNVs recorded in the ClinVar database 58 that were previously mapped 488 to canonical protein isoforms in ActiveDriverDB. Disease annotations of pSNVs were then 489 reviewed manually using the ClinVar website (data retrieved on Oct 6 th , 2021). Based on this 490 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint in the gnomAD dataset detected in at least one human population (AFpopmax ≥ 10 -4 ). The table  496 includes allele frequencies of pSNVs in the 16 populations in gnomAD (columns AF_all, 497

AF_popmax, etc.), the kinases known to target the site (column ptm_kinase), the probability of 498 the pSNV disrupting the phosphosite based on MIMP analysis (column top_MIMP_score; the 499 highest-ranking kinase motif), the predicted impact of the pSNV on the phosphorylation (column 500 pSNV_impact), and whether the pSNV affects multiple phosphosites (column multi_PTM). In 501 case of multiple sites, the phosphosite with highest MIMP probability is used for scoring (see 502

Supplementary Table 2) . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266712 doi: medRxiv preprint

Presenting Characteristics, Comorbidities, and Outcomes Among 549 5700 Patients Hospitalized With COVID-19 in the New York City Area

COVID-19 and Racial/Ethnic 552 Disparities

Ethnicity and COVID-19: an urgent public health research priority. The 554

The socio-economic implications of the coronavirus pandemic (COVID-556 19): A review

Genomewide Association Study of Severe Covid-19 558 with Respiratory Failure

Covid-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-561 19

Genetic mechanisms of critical illness in COVID-19

Interactome networks and human disease

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Triggering the interferon antiviral response through an IKK-related 569 pathway

TBK1 and IKKepsilon Act Redundantly to Mediate STING-Induced 571 NF-kappaB Responses in Myeloid Cells

An aberrant 574 STAT pathway is central to COVID-19

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-577 transcriptomics of SARS-CoV-2 infected cells

Activation and evasion of type I interferon responses by SARS-CoV-2. Nat 580 Commun 11

Evasion of Type I Interferon by SARS-CoV-2

COVID-19: A New Virus, but a Familiar Receptor and 584

Inter-proteomic posttranslational modifications of 587 the SARS-CoV-2 and the host proteins A new frontier

Loss of post-translational 590 modification sites in disease

Systematic analysis of somatic mutations in phosphorylation 592 signaling predicts novel cancer drivers. Molecular systems biology 9

Kinome-wide decoding of network-attacking mutations rewiring cancer 595 signaling

Pathogenic Germline Variants in 10,389 Adult Cancers

Evolutionary constraint and disease associations 599 of post-translational modification sites in human genomes

The mutational constraint spectrum quantified from variation in 602 141,456 humans

MIMP: predicting the impact of mutations on 604 kinase-substrate phosphorylation

Quantitative phosphoproteomics reveals extensive cellular 607 reprogramming during HIV-1 entry

Structure of the human activated spliceosome in three conformational 610 states

BUD13 Promotes a Type I Interferon Response by Countering Intron 612 Retention in Irf7

SARS-CoV-2 Disrupts Splicing, Translation, and Protein 614 Trafficking to Suppress Host Defenses

SARS-CoV-2 uses a multipronged strategy to impede host protein 617 synthesis

COVID19 Disease Map, a computational knowledge repository of 619 virus-host interaction mechanisms

Bclaf1 critically regulates the type I interferon response and is degraded by 622 alphaherpesvirus US3

Essential role for Bclaf1 in lung development and immune system 625 function

Phosphorylation of TRIM28 Enhances the Expression of IFN-beta 627 and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial 628 Cells

Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1

Ser-473 Phosphorylation in DNA Damage Response

TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2

COVID-19 in Children: Expressions of Type I/II/III Interferons

Retroviruses in Mild and Severe Cases

Integrative pathway enrichment analysis of multivariate omics 638 data

SARS-coronavirus replication is supported by a reticulovesicular 640 network of modified endoplasmic reticulum

Proteomics. Tissue-based map of the human proteome

The Novel Severe Acute Respiratory Syndrome Coronavirus

CoV-2) Directly Decimates Human Spleens and Lymph Nodes

Dysregulation of brain and choroid plexus cell types in severe COVID-648 19

Extrapulmonary manifestations of COVID-19

The BioGRID interaction database: 2019 update

ActiveDriverDB: Interpreting Genetic Variation in Human and 654

Individuals with obesity and COVID-19: A global perspective on the 657 epidemiology and biological relationships

Sequence Analysis and Structure Prediction of 660 SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close 661 Relatedness to Bat Coronavirus

The requirement of the DEAD-box protein DDX24 for the packaging of 664 human immunodeficiency virus type 1 RNA

Comparative host interactomes of the SARS-667

CoV-2 nonstructural protein 3 and human coronavirus homologs. bioRxiv

Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral 670 replication

Coronavirus nsp6 proteins generate autophagosomes from the 672 endoplasmic reticulum via an omegasome intermediate

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein 675 regulates GLUT4 translocation

TBC1D1 is a candidate for a severe obesity gene and evidence for a 678 gene/gene interaction in obesity predisposition

A common Greenlandic TBC1D4 variant confers muscle insulin 681 resistance and type 2 diabetes

Albumin Endocytosis in Proximal Tubule Epithelial Cells

Regulation of multisite phosphorylation and 14-3-3 binding of 686 AS160 in response to IGF-1, EGF, PMA and AICAR

A phospho-proteomic screen identifies substrates of the checkpoint 689 kinase Chk1

A genome-wide CRISPR screen identifies host factors that regulate SARS-691

CoV-2 entry

ClinVar: improvements to accessing data

PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

UniProt: a worldwide hub of protein knowledge

ELM: a database of phosphorylation sites--update

Human Protein Reference Database--2009 update

ANNOVAR: functional annotation of genetic 703 variants from high-throughput sequencing data

Gene ontology: tool for the unification of biology

The Reactome Pathway Knowledgebase

CORUM: the comprehensive resource of mammalian protein complexes-710 -2009

Profiler--a web-based toolset 712 for functional profiling of gene lists from large-scale experiments

Pathway enrichment analysis and visualization of omics data using 715 g:Profiler, GSEA, Cytoscape and EnrichmentMap

Integration of biological networks and gene expression data using 718